Medindia

X

Nuvilex Introduces Last Shot Hangover Remedy(TM) Video

Friday, September 18, 2009 General News J E 4
Advertisement


CHERRY HILL, N.J., Aug. 27 Nuvilex, Inc. (OTC Bulletin Board: NVLX), today announces that its Last Shot Hangover Remedy(TM) ("Last Shot") video commercial will begin airing on Monday, August 31, 2009. The video is a part of the Company's emerging Last Shot brand awareness campaign that will ultimately include television, radio, Internet, cinema spots, billboard, print and point-of-sale advertising. The video will initially be introduced to the public through the Internet. The video is adaptable for long and short segment play. The Last Shot video can be previewed from the Nuvilex (www.nuvilex.com) and Last Shot (www.mylastshot.com) web sites starting Friday, August 28, 2009.

About Nuvilex, Inc.

Nuvilex, Inc. is an emerging healthcare consumer products company. The Company's lead products include: Last Shot Hangover Remedy, a unique sugar-free, calorie-free and caffeine-free liquid formula designed to ease the symptoms of a hangover; Cinnergen, which promotes a healthy glucose metabolism; Cinnechol, designed to help maintain normal cholesterol levels and support normal cardiovascular function; and Infinitink( (R)), a permanent yet more easily removable tattoo ink. The Company's complete portfolio spans aesthetics, skin care, environmental and nutraceutical products, all of which are designed to directly or indirectly improve human health. In March 2009, Nuvilex merged with Freedom2 Holdings, Inc., the developer of Infinitink( (R)). In conjunction with the merger, the Company changed its name to Nuvilex, Inc. from eFoodSafety.com. Please visit www.nuvilex.com for additional information on the Company.

Safe Harbor Statement

Statements contained in this presentation that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Forward-looking statements are sometimes identified by words such as "intends", "anticipates", "believes", "expects", and "hopes" and involve a number of risks and uncertainties that could cause the Company's actual results to differ materially from projected results. All parties are cautioned that such forward-looking statements involve risks and uncertainties that could cause the Company's actual results to differ materially from those in these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company's products and services, the planned share exchange with Freedom2 Holdings, Inc., our ability to secure additional financing, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

Company Contact: Blair Barnes Senior Vice President and Chief Financial Officer Nuvilex, Inc. Ph: 856-433-6088 Email: bbarnes@nuvilex.com Press Contact: Pat Arcand Arcand & Madison Ph: 617-576-7777 Email: pat@am-pr.com

SOURCE Nuvilex, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Phoenix Cardiovascular Surgeon, David J. Caparrell...
S
Missouri Families to Demand Representative Blunt S...